Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer (Q43916071)

28 November 2017

title

Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer (English)

1 reference

28 November 2017

1 reference

Liu-Sheng Peng

1

1 reference

28 November 2017

Yuan Zhuang

2

1 reference

28 November 2017

Yun Shi

3

1 reference

28 November 2017

Yong-Liang Zhao

4

1 reference

28 November 2017

Ting-Ting Wang

5

1 reference

28 November 2017

Na Chen

6

1 reference

28 November 2017

Ping Cheng

7

1 reference

28 November 2017

Tao Liu

8

1 reference

28 November 2017

Xiao-Fei Liu

9

1 reference

28 November 2017

Jin-Yu Zhang

10

1 reference

28 November 2017

Qian-Fei Zuo

11

1 reference

28 November 2017

Xu-Hu Mao

12

1 reference

28 November 2017

Gang Guo

13

1 reference

28 November 2017

Dong-Shui Lu

14

1 reference

28 November 2017

Pei-Wu Yu

15

1 reference

28 November 2017

Quan-Ming Zou

16

1 reference

28 November 2017

publication date

22 May 2012

1 reference

Cancer Immunology, Immunotherapy

28 November 2017

published in

1 reference

28 November 2017

volume

61

1 reference

28 November 2017

issue

11

1 reference

28 November 2017

page(s)

2183-2192

1 reference

28 November 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Phenotypical and functional specialization of FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Expansion of regulatory CD8+ CD25+ T cells after neonatal alloimmunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

CD8+ regulatory T cells in persistent human viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Harnessing the immune response to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-β and retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1277-6

10.1007/S00262-012-1277-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1021051411

0 references

1 reference